|

Depression Clinical Trials in Oklahoma

29 recruiting studies across 2 cities

Browse by City

Oklahoma City
22 trials
Tulsa
8 trials

All Trials in Oklahoma

Phase
Trial Phase Dist.
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric PatientsPhase 3<1 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)Phase 3<1 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive DisorderPhase 3<1 mi
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)Phase 2<1 mi
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive DisorderPhase 2<1 mi
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive SymptomsPhase 4<1 mi
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant DepressionN/A<1 mi
A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive DisorderPhase 2<1 mi
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive DisorderPhase 2<1 mi
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.Phase 3<1 mi
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II DisorderPhase 2<1 mi
Study to Assess the Safety and Effectiveness of NMRA-335140-501Phase 3<1 mi
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)Phase 3<1 mi
Study of ALTO-300 in MDDPhase 2<1 mi
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive DisorderPhase 3<1 mi
BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and Early Post-Childbirth WomenN/A<1 mi
Clinical Trial on Agitation in Alzheimer's DementiaPhase 2<1 mi
E-Mindfulness Approaches for Living After Breast CancerPhase 3<1 mi
Effects of Acute Exercise and Ibuprofen on Symptoms, Immunity, and Neural Circuits in Bipolar DepressionPhase 1/2<1 mi
Evaluation of a Keto-Like Supplement on Brain Responses to Emotional Stimuli in DepressionPhase 2<1 mi
Neural Response to Inflammatory Challenge in Major Depressive DisorderPhase 1/2<1 mi
Ultrasound Neuromodulation of Circuits and Negative Valence Systems in Treatment-Resistant DepressionN/A<1 mi
Amplification of Positivity for Alcohol UseN/A<1 mi
Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and DepressionPhase 4<1 mi
Approach-Avoidance, Computational Framework for Predicting Behavioral Therapy Outcome (AAC-BeT)N/A<1 mi
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence StudyPhase 39 mi
The OBSERVE Protocol—9 mi
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)Phase 313 mi
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia SymptomsPhase 313 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.